Invention Grant
- Patent Title: MCP-1 binding nucleic acids
-
Application No.: US14246134Application Date: 2014-04-06
-
Publication No.: US09670491B2Publication Date: 2017-06-06
- Inventor: Werner Purschke , Florian Jarosch , Dirk Eulberg , Sven Klussmann , Klaus Buchner , Christian Maasch
- Applicant: NOXXON Pharma AG
- Applicant Address: DE Berlin
- Assignee: NOXXON Pharma AG
- Current Assignee: NOXXON Pharma AG
- Current Assignee Address: DE Berlin
- Agency: MDIP LLC
- Priority: EP06002935 20060214; EP06024202 20061122
- Main IPC: C07H21/02
- IPC: C07H21/02 ; A61K31/70 ; C12N15/113 ; C12N15/115 ; C12Q1/68 ; G01N33/566 ; C12N5/00
Abstract:
The present invention is related to a nucleic acid, preferably binding to MCP-1, selected from the group consisting of Type 1A nucleic acids, type 1B nucleic acids, Type 2 nucleic acids, Type 3 nucleic acids, Type 4 nucleic acids and nucleic acids comprising SEQ ID NOs:87-115
Public/Granted literature
- US20160208262A1 MCP-1 Binding Nucleic Acids Public/Granted day:2016-07-21
Information query
